Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Silicon | 1 | 2022 | 20 | 0.710 |
Why?
|
| Quantum Theory | 1 | 2022 | 40 | 0.710 |
Why?
|
| Rectal Neoplasms | 3 | 1994 | 132 | 0.250 |
Why?
|
| Receptors, Progesterone | 6 | 1988 | 195 | 0.240 |
Why?
|
| Colonic Neoplasms | 4 | 1993 | 578 | 0.200 |
Why?
|
| Receptors, Estrogen | 5 | 1988 | 412 | 0.190 |
Why?
|
| Biopsy, Needle | 3 | 1993 | 226 | 0.190 |
Why?
|
| Breast Neoplasms | 10 | 1995 | 3155 | 0.180 |
Why?
|
| Electrons | 1 | 2022 | 51 | 0.180 |
Why?
|
| Megestrol | 3 | 1988 | 4 | 0.140 |
Why?
|
| Carcinoma | 3 | 1991 | 439 | 0.140 |
Why?
|
| Liver | 2 | 1995 | 1206 | 0.140 |
Why?
|
| Cholecystectomy, Laparoscopic | 2 | 1993 | 52 | 0.110 |
Why?
|
| Liver Regeneration | 1 | 1995 | 34 | 0.110 |
Why?
|
| Radiation Tolerance | 1 | 1995 | 175 | 0.110 |
Why?
|
| Neoplasm Metastasis | 5 | 1995 | 1060 | 0.100 |
Why?
|
| Mastectomy | 2 | 1995 | 262 | 0.100 |
Why?
|
| Breast | 2 | 1995 | 302 | 0.100 |
Why?
|
| Thyroid Nodule | 1 | 1993 | 60 | 0.090 |
Why?
|
| Thoracotomy | 1 | 1993 | 68 | 0.090 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 1992 | 16 | 0.090 |
Why?
|
| Molybdenum | 3 | 1980 | 11 | 0.090 |
Why?
|
| Cytosol | 3 | 1980 | 192 | 0.090 |
Why?
|
| Ileum | 1 | 1992 | 167 | 0.090 |
Why?
|
| Breast Diseases | 2 | 1991 | 99 | 0.080 |
Why?
|
| Parathyroid Glands | 2 | 1988 | 75 | 0.080 |
Why?
|
| Chitin | 1 | 1990 | 10 | 0.080 |
Why?
|
| Rats, Inbred Strains | 4 | 1992 | 300 | 0.080 |
Why?
|
| Wound Healing | 1 | 1992 | 372 | 0.080 |
Why?
|
| Hemostatics | 1 | 1990 | 60 | 0.070 |
Why?
|
| Hyperthermia, Induced | 1 | 1990 | 75 | 0.070 |
Why?
|
| Thyroid Neoplasms | 2 | 1993 | 441 | 0.070 |
Why?
|
| Nervous System Neoplasms | 1 | 1988 | 10 | 0.070 |
Why?
|
| Choriocarcinoma | 1 | 1988 | 7 | 0.070 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1990 | 129 | 0.070 |
Why?
|
| Thyroid Diseases | 1 | 1989 | 106 | 0.070 |
Why?
|
| Endocrine System Diseases | 1 | 1988 | 24 | 0.070 |
Why?
|
| Rats | 6 | 1995 | 4028 | 0.070 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 1988 | 42 | 0.070 |
Why?
|
| Laser Therapy | 1 | 1990 | 150 | 0.070 |
Why?
|
| Gallium Radioisotopes | 1 | 1988 | 18 | 0.070 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 1988 | 2543 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 1990 | 501 | 0.060 |
Why?
|
| Cyclosporins | 1 | 1987 | 56 | 0.060 |
Why?
|
| Aged | 12 | 1995 | 20395 | 0.060 |
Why?
|
| Middle Aged | 15 | 1995 | 27535 | 0.060 |
Why?
|
| Aged, 80 and over | 7 | 1995 | 7039 | 0.060 |
Why?
|
| Laparoscopy | 1 | 1993 | 765 | 0.060 |
Why?
|
| Retrospective Studies | 7 | 1995 | 10128 | 0.060 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 1987 | 247 | 0.050 |
Why?
|
| Female | 16 | 1995 | 48542 | 0.050 |
Why?
|
| Adult | 11 | 1995 | 27849 | 0.050 |
Why?
|
| Internship and Residency | 1 | 1993 | 1074 | 0.050 |
Why?
|
| Melanoma | 1 | 1988 | 494 | 0.050 |
Why?
|
| Random Allocation | 2 | 1995 | 308 | 0.050 |
Why?
|
| Megestrol Acetate | 3 | 1988 | 9 | 0.050 |
Why?
|
| Graft Survival | 1 | 1987 | 939 | 0.050 |
Why?
|
| Humans | 23 | 1995 | 93132 | 0.050 |
Why?
|
| Neoplasm Staging | 4 | 1994 | 2009 | 0.050 |
Why?
|
| Male | 12 | 1995 | 44355 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 1993 | 2363 | 0.040 |
Why?
|
| Regression Analysis | 2 | 1994 | 573 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 2 | 1991 | 241 | 0.040 |
Why?
|
| Prognosis | 3 | 1993 | 3890 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 1993 | 1519 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 1994 | 1703 | 0.030 |
Why?
|
| Tamoxifen | 2 | 1988 | 170 | 0.030 |
Why?
|
| Cholangiography | 2 | 1993 | 38 | 0.030 |
Why?
|
| Mammography | 2 | 1991 | 494 | 0.030 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1995 | 23 | 0.030 |
Why?
|
| Mastectomy, Modified Radical | 1 | 1995 | 6 | 0.030 |
Why?
|
| Mastectomy, Radical | 1 | 1995 | 10 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 1995 | 72 | 0.030 |
Why?
|
| Aspartate Aminotransferases | 1 | 1995 | 71 | 0.030 |
Why?
|
| Mastectomy, Subcutaneous | 1 | 1995 | 8 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 1990 | 1786 | 0.030 |
Why?
|
| Animals | 6 | 1995 | 27973 | 0.030 |
Why?
|
| Bilirubin | 1 | 1995 | 133 | 0.030 |
Why?
|
| Carcinoma, Lobular | 1 | 1995 | 83 | 0.030 |
Why?
|
| Hepatectomy | 1 | 1995 | 177 | 0.030 |
Why?
|
| Prospective Studies | 3 | 1993 | 4546 | 0.030 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 1995 | 165 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 1993 | 59 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 1993 | 212 | 0.020 |
Why?
|
| Lymphatic Metastasis | 2 | 1994 | 505 | 0.020 |
Why?
|
| Anastomosis, Surgical | 2 | 1992 | 280 | 0.020 |
Why?
|
| Cholecystectomy | 1 | 1993 | 26 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 1993 | 93 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1995 | 1236 | 0.020 |
Why?
|
| Pilot Projects | 1 | 1995 | 913 | 0.020 |
Why?
|
| Hydroxyproline | 1 | 1992 | 11 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 1994 | 570 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 1994 | 1909 | 0.020 |
Why?
|
| Risk Factors | 2 | 1994 | 5900 | 0.020 |
Why?
|
| Tensile Strength | 1 | 1992 | 86 | 0.020 |
Why?
|
| Biopsy | 1 | 1995 | 1172 | 0.020 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 2 | 1991 | 121 | 0.020 |
Why?
|
| Palpation | 1 | 1991 | 19 | 0.020 |
Why?
|
| Fibroma | 1 | 1991 | 30 | 0.020 |
Why?
|
| Carcinoma in Situ | 1 | 1991 | 53 | 0.020 |
Why?
|
| Stereotaxic Techniques | 1 | 1991 | 81 | 0.020 |
Why?
|
| Killer Cells, Lymphokine-Activated | 1 | 1989 | 27 | 0.020 |
Why?
|
| Chitosan | 1 | 1990 | 17 | 0.020 |
Why?
|
| Incidence | 1 | 1994 | 1697 | 0.020 |
Why?
|
| Survival Rate | 1 | 1993 | 1945 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1989 | 208 | 0.020 |
Why?
|
| Xeromammography | 1 | 1988 | 1 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 1995 | 2479 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1988 | 429 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 1988 | 56 | 0.020 |
Why?
|
| HLA-D Antigens | 1 | 1988 | 20 | 0.020 |
Why?
|
| HLA-DQ Antigens | 1 | 1988 | 51 | 0.020 |
Why?
|
| Menopause | 1 | 1988 | 87 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 1988 | 180 | 0.020 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1988 | 124 | 0.020 |
Why?
|
| Clinical Competence | 1 | 1993 | 810 | 0.020 |
Why?
|
| Remission Induction | 1 | 1988 | 737 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1987 | 171 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 1988 | 308 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 1991 | 1910 | 0.010 |
Why?
|
| Postoperative Complications | 2 | 1993 | 2552 | 0.010 |
Why?
|
| Islets of Langerhans | 1 | 1988 | 556 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 1987 | 1014 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 1990 | 1611 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 1988 | 538 | 0.010 |
Why?
|
| Algorithms | 1 | 1991 | 1948 | 0.010 |
Why?
|
| Charcoal | 1 | 1980 | 14 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1980 | 93 | 0.010 |
Why?
|
| Dextrans | 1 | 1980 | 77 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 1987 | 814 | 0.010 |
Why?
|
| Tritium | 1 | 1980 | 113 | 0.010 |
Why?
|
| Promegestone | 1 | 1980 | 4 | 0.010 |
Why?
|
| Progesterone | 1 | 1980 | 114 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1980 | 944 | 0.010 |
Why?
|
| Uterus | 1 | 1980 | 225 | 0.010 |
Why?
|
| Melphalan | 1 | 1977 | 98 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1988 | 3450 | 0.010 |
Why?
|
| Age Factors | 1 | 1980 | 1898 | 0.010 |
Why?
|
| Fluorouracil | 1 | 1977 | 524 | 0.010 |
Why?
|
| Adolescent | 1 | 1988 | 9550 | 0.010 |
Why?
|
| Puerto Rico | 1 | 1993 | 34 | 0.010 |
Why?
|
| Bile Ducts | 1 | 1993 | 61 | 0.010 |
Why?
|
| Laparotomy | 1 | 1993 | 63 | 0.010 |
Why?
|
| Morbidity | 1 | 1993 | 162 | 0.010 |
Why?
|
| Intraoperative Care | 1 | 1993 | 88 | 0.010 |
Why?
|
| Data Collection | 1 | 1993 | 370 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 1993 | 191 | 0.010 |
Why?
|
| Eicosanoids | 1 | 1989 | 17 | 0.000 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1989 | 215 | 0.000 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1988 | 43 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1988 | 306 | 0.000 |
Why?
|
| Inguinal Canal | 1 | 1987 | 6 | 0.000 |
Why?
|
| Rats, Inbred WF | 1 | 1987 | 11 | 0.000 |
Why?
|
| Rats, Inbred Lew | 1 | 1987 | 214 | 0.000 |
Why?
|
| Femoral Vein | 1 | 1987 | 42 | 0.000 |
Why?
|
| Femoral Artery | 1 | 1987 | 90 | 0.000 |
Why?
|
| ROC Curve | 1 | 1988 | 774 | 0.000 |
Why?
|
| Aorta | 1 | 1987 | 273 | 0.000 |
Why?
|
| Pulmonary Artery | 1 | 1987 | 333 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1989 | 2827 | 0.000 |
Why?
|
| Immunotherapy | 1 | 1989 | 762 | 0.000 |
Why?
|
| United States | 1 | 1993 | 7581 | 0.000 |
Why?
|
| Leukopenia | 1 | 1977 | 64 | 0.000 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 1977 | 50 | 0.000 |
Why?
|
| Thrombocytopenia | 1 | 1977 | 189 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1977 | 753 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1977 | 1098 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1977 | 1447 | 0.000 |
Why?
|